Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.04.11.648479

GLUT4 translocation with insulin: revisiting the case for dose-dependent quantal release

Abstract

In mammalian fat and muscle cells, insulin stimulates the translocation of the glucose transporter GLUT4 from intracellular storage compartments to the plasma membrane in adipocytes and muscle cells, significantly increasing glucose uptake. In unstimulated (basal) cells, GLUT4 is sequestered in non-cycling/very slowly cycling compartments. Insulin mobilizes GLUT4 by releasing it from sequestration, enabling its exocytosis and continuous cycling between the plasma membrane and endosomes. Upon insulin withdrawal, GLUT4 is rapidly internalized and re-sequestered internally for future activation. Dynamic studies using tagged GLUT4 have revealed that this trafficking mechanism is regulated post-translationally, with GLUT4 undergoing repeated cycles of mobilization and sequestration in response to fluctuating insulin levels. The trafficking of GLUT4 under basal and maximal insulin concentrations can be modeled as a single cycling pool, with different amounts of GLUT4 in the actively cycling pool. In this model, insulin regulates both the rate constant of exocytosis, kex, and the distribution of GLUT4 between the cycling and a non-cycling pool. Here, we present modeling of the kinetics of GLUT4 trafficking in 3T3-L1 adipocytes over a range of insulin concentrations, under steady state, and in transition after adding insulin or after adding an inhibitor of exocytosis. Given the observed characteristics of the experimental data, parsimonious explanatory models incorporating different hypotheses of the insulin-dependence of the GLUT4 recycling system are optimized to the data sets to identify dominant processes acting in the dynamics. The steady-state data is best fit with a model that includes a dose-dependent increase in the size of the cycling pool at submaximal insulin concentrations (quantal release). Simultaneous fits of the transition and steady-state data indicate that insulin regulates a second kinetics rate constant, in addition to increasing kex and the cycling pool size. SummaryExperimental and modeling investigations of the trafficking of GLUT4 in 3T3-L1 adipocytes at different insulin doses shows the dominant effects of the insulin dose on the dynamics. The data is best fit, particularly at submaximal insulin concentrations, by a model in which both the exocytosis rate and the size of the cycling pool increases with insulin.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Romenskaia, I., Mastick, C. C., Coster, A.. 2025-04-12. GLUT4 translocation with insulin: revisiting the case for dose-dependent quantal release. https://doi.org/10.1101/2025.04.11.648479

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Deep reinforcement learning-driven discovery of a MsbA-targeted small-molecule antibiotic for the treatment of Acinetobacter baumannii infection

Antibiotics with new mechanisms are highly pursued to address the threat of infections caused by drug-resistant Gram-negative bacteria. Targeting MsbA, a key protein of the lipopolysaccharide biosynthesis pathway, represents a promising strategy to discover new classes of antibiotics. However, currently available MsbA-targeted molecules either lack sufficient potency or have unfavorable properties, necessitating expansion of chemical space. In this study, we chose the most promising cerastecin Cpd 4 as the template, and used two Artificial Intelligence (AI)-based tools, i.e. Link-INVENT and AutoMolDesigner for molecular design, performed chemical derivatization and antibacterial activity evaluation, which led to the discovery of Y-11 (MIC for A. baumannii: 0.5 g/mL). Encouragingly, Y-11 showed equivalent potency to Cpd4 for carbapenem-resistant A. baumannii, and less cytotoxicity and hemolysis as well as lower spontaneous resistance frequency. In vivo efficacy study demonstrated that Y-11 could effectively reduce bacterial loads in the mice infected by A. baumannii. The following mechanism study including molecular dynamics simulation, biochemical assay, and transmission electron microscope (TEM) analysis suggested that Y-11 inhibited the transport of lipooligosaccharide and impaired the formation of outer membrane, probably by competitively binding to the substrate binding site of MsbA and modulating ATPase activity. Taken together, we have discovered a MsbA-targeted small molecule Y-11 via AI-driven drug design, which provides a foundation for future antibiotic development.

biochemistry↗

Dynamic architecture of the Rixosome reveals mechanism of activation and ITS2 processing

Eukaryotic ribosome assembly requires the coordinated processing and extensive remodeling of pre-rRNAs. During late nuclear maturation of the 60S subunit, sequential removal of the internal transcribed spacer 2 (ITS2) is initiated by endonucleolytic cleavage at site C2 by the conserved Las1 nuclease. Las1 acts together with the kinase Grc3 and the Rix1 complex to form the Rixosome, which also functions in transcriptional regulation. However, the assembly of the Rixosome, its recruitment to pre-ribosomes, and its activation for ITS2 cleavage remain unclear. Here, we present cryo-EM structures of the human LAS1 complex, two structures of the isolated Rixosome and nine transition states of Rix1-bound pre-60S particles from Schizosaccharomyces pombe. These structures reveal a dynamic Rixosome architecture in which the heterotetrameric Las1 complex engages one or two copies of the Rix1 complex. Rix1 binding is highly flexible in the human Rixosome but rigid in the yeast complex. The isolated yeast Rixosome remains inactive, but binding to the pre-60S particle triggers a structural rearrangement that allows for substrate engagement and activation of the nuclease. Together, our results define the dynamic architecture of the Rixosome and provide a structural framework for ITS2 processing during nuclear maturation of the eukaryotic 60S ribosomal subunit.

biochemistry↗

SGFP-Grid Split GFP Graphene Grids

Affinity graphene grids provide a promising approach for selective protein capture in cryo-EM. Here, we introduce a split-GFP graphene grid platform(SGFP-G), in which graphene-conjugated GFP 1-10 selectively captures GFP11 tagged proteins from low concentration samples or cell lysates. This platform enables rapid assessment of target protein enrichment and particle distribution before vitrification via fluorescence imaging, while the grid design positions captured proteins away from the graphene surface and air-water interface. We also introduce a unique strategy to minimize nonspecific protein adsorption, thereby improving the selective enrichment of target proteins on this grid. Using GFP11-tagged apoferritin, we demonstrate fluorescence guided protein capture and obtain a 2.58 [A] cryoEM reconstruction, establishing SGFP-G as an affinity grid platform for high resolution structural studies with reduced sample requirements.

biochemistry↗